Associated Banc-Corp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35M Sell
143,311
-3,181
-2% -$741K 0.93% 26
2025
Q4
$30.3M Sell
146,492
-2,678
-2% -$530K 0.78% 34
2025
Q3
$27.7M Buy
149,170
+3,567
+2% +$611K 0.73% 35
2025
Q2
$22.2M Sell
145,603
-3,508
-2% -$539K 0.63% 41
2025
Q1
$24.7M Sell
149,111
-5,087
-3% -$796K 0.75% 39
2024
Q4
$22.3M Sell
154,198
-8,676
-5% -$1.34M 0.67% 43
2024
Q3
$26.4M Sell
162,874
-4,932
-3% -$786K 0.78% 37
2024
Q2
$24.5M Sell
167,806
-3,469
-2% -$516K 0.76% 37
2024
Q1
$27.1M Sell
171,275
-2,033
-1% -$324K 0.86% 35
2023
Q4
$27.2M Sell
173,308
-5,085
-3% -$780K 0.94% 29
2023
Q3
$27.8M Sell
178,393
-38
-0% -$6.27K 1.08% 24
2023
Q2
$29.5M Sell
178,431
-714
-0.4% -$115K 1.12% 23
2023
Q1
$27.8M Sell
179,145
-1,179
-0.7% -$190K 1.12% 22
2022
Q4
$31.9M Buy
180,324
+1,379
+0.8% +$238K 1.33% 19
2022
Q3
$29.2M Buy
178,945
+421
+0.2% +$71.2K 1.35% 17
2022
Q2
$31.7M Buy
178,524
+87
+0% +$15.5K 1.39% 16
2022
Q1
$31.6M Sell
178,437
-4,559
-2% -$776K 1.22% 19
2021
Q4
$31.3M Sell
182,996
-1,908
-1% -$312K 1.15% 21
2021
Q3
$29.9M Sell
184,904
-469
-0.3% -$80K 1.18% 22
2021
Q2
$30.5M Sell
185,373
-8,960
-5% -$1.48M 1.21% 20
2021
Q1
$25.5M Sell
194,333
-14,622
-7% -$2.37M 1.58% 14
2020
Q4
$32.9M Sell
208,955
-6,767
-3% -$999K 1.28% 17
2020
Q3
$32.1M Sell
215,722
-3,884
-2% -$575K 1.38% 14
2020
Q2
$30.9M Sell
219,606
-9,323
-4% -$1.36M 1.39% 13
2020
Q1
$30M Buy
228,929
+37,306
+19% +$5.29M 1.6% 12
2019
Q4
$28M Buy
191,623
+3,811
+2% +$517K 1.39% 19
2019
Q3
$24.3M Buy
187,812
+4,636
+3% +$611K 1.31% 18
2019
Q2
$25.5M Buy
183,176
+6,348
+4% +$879K 1.4% 18
2019
Q1
$24.7M Sell
176,828
-5,594
-3% -$749K 1.42% 18
2018
Q4
$23.5M Buy
182,422
+910
+0.5% +$127K 1.53% 12
2018
Q3
$25.1M Sell
181,512
-6,081
-3% -$808K 1.39% 15
2018
Q2
$22.8M Sell
187,593
-4,828
-3% -$602K 1.33% 18
2018
Q1
$24.7M Sell
192,421
-3,154
-2% -$426K 1.4% 13
2017
Q4
$27.3M Sell
195,575
-1,223
-0.6% -$170K 1.47% 10
2017
Q3
$25.6M Buy
196,798
+2,195
+1% +$291K 1.41% 12
2017
Q2
$25.7M Buy
194,603
+8,981
+5% +$1.15M 1.46% 11
2017
Q1
$23.1M Buy
185,622
+8,866
+5% +$1.06M 1.38% 14
2016
Q4
$20.4M Buy
176,756
+4,846
+3% +$560K 1.27% 20
2016
Q3
$20.3M Buy
171,910
+730
+0.4% +$88.6K 1.29% 16
2016
Q2
$20.8M Sell
171,180
-2,869
-2% -$326K 1.33% 17
2016
Q1
$18.8M Buy
174,049
+418
+0.2% +$43.3K 1.24% 18
2015
Q4
$17.8M Sell
173,631
-559
-0.3% -$56.2K 1.18% 22
2015
Q3
$16.3M Sell
174,190
-161
-0.1% -$15.6K 1.13% 22
2015
Q2
$17M Sell
174,351
-20,972
-11% -$2.1M 1.09% 23
2015
Q1
$19.6M Buy
195,323
+18
+0% +$1.83K 1.24% 16
2014
Q4
$20.4M Buy
195,305
+1,424
+0.7% +$150K 1.29% 16
2014
Q3
$20.7M Buy
193,881
+357
+0.2% +$37K 1.36% 15
2014
Q2
$20.2M Buy
193,524
+3,687
+2% +$373K 1.32% 14
2014
Q1
$18.6M Buy
189,837
+9,343
+5% +$866K 1.29% 13
2013
Q4
$16.5M Sell
180,494
-145
-0.1% -$13.4K 1.19% 16
2013
Q3
$15.7M Sell
180,639
-3,118
-2% -$280K 1.24% 16
2013
Q2
$15.8M Buy
+183,757
New +$15.6M 1.3% 15

Other funds holding JNJ

Associated Banc-Corp's JNJ Position: Q1 2026 in Review

Associated Banc-Corp reduced its Johnson & Johnson (JNJ) stake by 2.2% in Q1 2026, selling an estimated $741K and leaving 143,311 shares worth $35M. The position accounts for 0.93% of the portfolio, ranked #26.

Associated Banc-Corp first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Associated Banc-Corp held 143,311 shares of Johnson & Johnson worth $35M as of Q1 2026.
  • Associated Banc-Corp sold 3,181 Johnson & Johnson shares in Q1 2026, an estimated $741K.
  • Johnson & Johnson made up 0.93% of Associated Banc-Corp's portfolio in Q1 2026, its #26 holding.
  • Associated Banc-Corp first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.